Johnson & Johnson
JNJ
$155.66
-$1.64-1.04%
NYSE
| 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.89B | 22.52B | 22.47B | 22.45B | 21.38B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.89B | 22.52B | 22.47B | 22.45B | 21.38B |
| Cost of Revenue | 7.25B | 6.91B | 6.76B | 6.87B | 6.50B |
| Gross Profit | 14.64B | 15.61B | 15.71B | 15.58B | 14.88B |
| SG&A Expenses | 4.98B | 6.23B | 5.25B | 5.45B | 5.03B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.46B | 18.43B | 16.96B | 15.75B | 15.07B |
| Operating Income | 6.44B | 4.09B | 5.51B | 6.69B | 6.31B |
| Income Before Tax | 13.63B | 3.89B | 3.34B | 5.75B | 3.71B |
| Income Tax Expenses | 2.63B | 456.00M | 644.00M | 1.06B | 459.00M |
| Earnings from Continuing Operations | 11.00B | 3.43B | 2.69B | 4.69B | 3.26B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.00B | 3.43B | 2.69B | 4.69B | 3.26B |
| EBIT | 6.44B | 4.09B | 5.51B | 6.69B | 6.31B |
| EBITDA | 8.21B | 5.98B | 7.36B | 8.48B | 8.13B |
| EPS Basic | 4.57 | 1.41 | 1.12 | 1.95 | 1.35 |
| Normalized Basic EPS | 1.80 | 1.09 | 1.58 | 1.83 | 1.74 |
| EPS Diluted | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 |
| Normalized Diluted EPS | 1.79 | 1.09 | 1.57 | 1.81 | 1.72 |
| Average Basic Shares Outstanding | 2.41B | 2.43B | 2.41B | 2.41B | 2.41B |
| Average Diluted Shares Outstanding | 2.42B | 2.43B | 2.43B | 2.42B | 2.43B |
| Dividend Per Share | 1.24 | 1.24 | 1.24 | 1.24 | 1.19 |
| Payout Ratio | 27.18% | 86.97% | 110.80% | 63.70% | 88.14% |